SCHEMBL3744740

SCHEMBL3744740

Cc1c(C)c2ccc(Br)cc2c2cc(Br)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.42
KIT P10721 1/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 2/20 0.40
KMT2A Q03164 2/20 0.39
RXFP1 Q9HBX9 2/20 0.37
MEN1 O00255 1/20 0.37
CYP2A6 P11509 2/20 0.37
JAK2 O60674 3/20 0.37
METAP2 P50579 1/20 0.37
CHEK1 O14757 1/20 0.37
AURKA O14965 1/20 0.37
DAPK3 O43293 1/20 0.37
PRKD3 O94806 1/20 0.37
MAP4K4 O95819 1/20 0.37
PAK4 O96013 1/20 0.37
ABL1 P00519 1/20 0.37
NTRK1 P04629 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28583244 0.91 KMT2A (0.44) ESR2KITALDH1A1LMNAHPGD
SCHEMBL57643 0.89 ESR2 (0.46) ESR2KITALDH1A1LMNAHPGD
SCHEMBL14099591 0.89 ESR2 (0.42) ESR2KITALDH1A1LMNAHPGD
SCHEMBL19757717 0.85 ESR2 (0.41) ESR2KITALDH1A1LMNAHPGD
SCHEMBL19713318 0.82 MAPK1 (0.43) ESR2KITALDH1A1LMNAHPGD
SCHEMBL16158369 0.82 CYP2A6 (0.47) ESR2ALDH1A1MAPK1KMT2ARXFP1
SCHEMBL28276718 0.80 ALDH1A1 (0.46) ESR2KITALDH1A1LMNAHPGD
SCHEMBL12377924 0.80 RXFP1 (0.41) ESR2KITALDH1A1LMNAHPGD
SCHEMBL28583249 0.79 ALDH1A1 (0.47) ESR2ALDH1A1MAPK1KMT2ARXFP1
SCHEMBL31049230 0.77 BCL2 (0.50) ALDH1A1MAPK1KMT2ARXFP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100288974-A1 ELECTROLUMINESCENT POLYMERS AND USE THEREOF MERCK PATENT GMBH (DE) 2010-11-18 US disclosed
US-20100288974-A1 ELECTROLUMINESCENT POLYMERS AND USE THEREOF MERCK PATENT GMBH (DE) 2010-11-18 US disclosed
US-20100288974-A1 ELECTROLUMINESCENT POLYMERS AND USE THEREOF MERCK PATENT GMBH (DE) 2010-11-18 US disclosed
EP-1913797-A1 ELECTROLUMINESCENT POLYMERS AND USE THEREOF Merck Patent GmbH (DE) 2008-04-23 EP disclosed
US-20070191583-A1 Polymers based on 3,6-and 2,7-conjugated poly(phenanthrene) and pled devices MAX-PLANCK-SOCIETY (DE) 2007-08-16 US disclosed
US-20070152209-A1 Devices using polymers based on 3,6- and 2,7-conjugated poly(phenanthrene) E. I. DU PONT DE NEMOURS AND COMPANY 2007-07-05 US disclosed
WO-2007017066-A1 ELECTROLUMINESCENT POLYMERS AND USE THEREOF MERCK PATENT GMBH (DE) 2007-02-15 WO disclosed
WO-2007017066-A1 ELECTROLUMINESCENT POLYMERS AND USE THEREOF MERCK PATENT GMBH (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100288974-A1 ELECTROLUMINESCENT POLYMERS AND USE THEREOF EPN1, PUF60, MAP1LC3C ESR2 1273/4885KIT 3529/4885ALDH1A1 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.